Clinical Trials Browser

Phase 1/2 × Leukemia, Myelomonocytic, Juvenile × Mitoxantrone × Clear all

NCT00609739 2017-12-28

Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation

Phase 1/2 Terminated

1 enrolled 7 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myelomonocytic, Juvenile